96 pages • 3 hours read
Walter IsaacsonA modern alternative to SparkNotes and CliffsNotes, SuperSummary offers high-quality Study Guides with detailed chapter summaries and analysis of major themes, characters, and more.
Summary
Chapter Summaries & Analyses
Key Figures
Themes
Symbols & Motifs
Important Quotes
Essay Topics
Tools
The word “collaboration” crops up almost 80 times in the text of The Code Breaker, besides showing up in references and acknowledgements. It’s not merely a matter of semantics; scientific collaboration forms the backbone of most of the important discoveries detailed in the book. Though the book is partly a biography of Jennifer Doudna, it is also an ode to all the scientists who made accomplishments in gene editing possible. Isaacson stresses the point by drawing a line from Yoshizumi Ishino, who first noticed spacer sequences in E. coli, to Francisco Mojica, who discovered these sequences were immune mechanism CRISPRs, to Doudna, whose focused on uncovering how CRISPR works. The line stretches through geographies and generations, as Ishino worked in Japan, Mojica in Spain, and Doudna in Berkeley. It connects Gregor Mendel in the late 1850s to Emmanuelle Charpentier in 2011. Further, there is a clear cause-and-effect chain linking these scientists. If Mojica hadn’t read the works of Ishino, or if Jiankui hadn’t heard about the CCR5 enzyme from George Church, would they have made their discoveries? The line also takes the form of inspiration. Doudna’s scientific outlook was forged by reading James Watson’s The Double Helix, and Charpentier was inspired when she passed by the Pasteur Institute. Charles Darwin also counted economist Thomas Malthus as the chief inspiration behind On the Origin of Species (1858).
Isaacson presents science as a team sport. It is telling that when speculating about a potential third recipient of the 2020 Nobel Prize, which was awarded to Doudna and Charpentier, Isaacson mentions six scientists. Thus, even while celebrating Doudna and Charpentier’s success, he doesn’t let the other CRISPR heroes fade out of the limelight. The story of CRISPR highlights the highly collaborative nature of 21st-century science, as information technology enables researchers to know what is happening in competing labs. Then there is the actual physical collaboration in labs, conferences, and seminars, which Isaacson champions above all. When scientists bring problems to each other in real life, a fresh set of eyes spots solutions. In Chapter 24 it is Luciano Marraffini who urges Zhang to focus mainly on the Cas9 enzyme. When Alexandra East doubts her experiments in Chapter 25, Doudna immediately spots that East has in fact successfully inserted CRISPR into a human cell. The data belongs to East, while the interpretation is Doudna’s: this is the way most lab collaborations blossom.
Isaacson also emphasizes the value of small meetings like the freewheeling exchange of ideas between Doudna and Australian biologist Jillian Banfield, who introduced Doudna to CRISPRs. Similarly fruitful was the 2011 Puerto Rico meeting between Doudna and Charpentier. Would the field of CRISPR be the same without these in-person meetings? The text suggests otherwise. In fact, one of Isaacson’s few grouses about the age of technology is that it has reduced in-person interaction. Isaacson fears the surge in virtual conferences signals the end of the inspiration that in-person collaboration ignites.
From the 19th century onward, literature and art have often warned against the perils of interfering with the natural human being, as seen in Mary Shelley’s Frankenstein; or, the Modern Prometheus (1818). In Frankenstein the eponymous doctor creates a human being from the parts of corpses but later abandons “playing God,” for even Prometheus was considered a sacrilege. After all, Prometheus, who in Greek mythology stole the fire of the gods for humanity, was condemned to have his liver perennially eaten by vultures. However, Prometheus is also a heroic figure who represents humanity’s ambition. The arguments for and against gene editing follow a similar binary: it might bring about chaos, or it might herald a better future for humans.
The idea of engineering humans became a distinct possibility with the use of recombinant or hybrid DNA in the 1970s. From then on, the field of genetic engineering has leapfrogged into gene editing. Using CRISPR systems, short segments of RNA can guide a scissors-like enzyme to cut up genetic material even in human cells. This could mean deleting genes or mutations that code for terrible diseases like sickle-cell anemia, Huntington’s disease, Alzheimer’s disease, cancer, and more. Though this is a great development in principle, in practice things may play out differently. For example, the sickle-cell gene can also give immunity against malaria, which is endemic in sub-Saharan Africa, where most sickle-cell sufferers live. In this case, who decides which risk is worth taking?
The debate gets even more heated when it comes to the question of editing germ or reproductive cells. Genetic edits in these cells are permanent, so the offspring inherits the edits. Again, if it was simply about editing genes for autoimmune diseases, the question would be simple. However, Isaacson considers another complication: What if the edit is not medically unnecessary? And what if it is about enhancing a trait, like IQ or height, or even eye or skin color? The implications of making such changes freely available in a world riddled with racism and gender injustice must be considered very deeply. The concern came into international spotlight in 2018, when He Jiankui, a Chinese biotechnologist trained in America, reported that he had edited out a gene linked with HIV in embryos, implanted them in wombs of couples who had signed up for the process, and delivered “healthy” children. Jiankui defended his experiments on the basis that HIV-positive individuals are stigmatized in China, and he wanted to give the twins a chance for a better life.
Further, the information in human genes creates diversity. Would tweaking the genome eliminate diversity? Would Eurocentric ideas of intelligence or beauty dictate these tweaks? It’s also possible that fiddling with the genome would create more problems than it solves. For instance, editing the gene for mental illness might curb creativity. Moreover, there are also questions around whether a parent has the right to decide what constitutes a potential disability for a child. What if a parent thinks being female is a disability? Such gray areas make the concept of gene editing a minefield to explore.
Some objections to gene editing deal more with philosophical and religious considerations. Does gene editing interfere with the natural order? In pursuing gene editing to any end, are scientists attempting to play God? However, Doudna makes a pertinent response to such questions: Who decides what is natural and unnatural? Pursuing that argument, it can be postulated that all medicine interferes or intervenes with the natural course of things. Should cancers then be left untreated and polio vaccines left unadministered?
The two most pertinent arguments for caution in gene editing address more secular concerns. Since gene-editing treatments are prohibitively expensive, they can aggravate inequality. The world’s inequality problem will be further exacerbated if gene editing is made available in the free market, as richer parents will be able to buy their children better genes.
Finally, it remains true that suffering builds character and empathy. Would Franklin Roosevelt have been Franklin Roosevelt without polio, or Sylvia Plath herself without depression? Would Flannery O’Connor have been the writer she was had she not suffered from the autoimmune disease lupus? It can also be argued that with perfection becoming the norm, people will lose empathy for those considered imperfect. The text concludes that the best way to negotiate these tricky questions is to include humanists in formulating guidelines for gene editing.
One of the most prominent themes in The Code Breaker is the growing importance of biotechnology. In fact, biotechnology is so crucial that Isaacson believes it is the digital revolution of the future. Early in the text he predicts that “we have entered a […] momentous era, a life-science revolution,” and that children who study digital coding will be joined by those who study genetic code” (11). Isaacson bases his prediction on a central point: Biotech will soon become easy to use, much like computers and smartphones. Once a technology becomes widespread, it turns into a revolution. The digital revolution kickstarted with the invention of the PC; now children are coding and creating digital content. As technologies like CRISPR are posed to make easy-to-use diagnostic tests available to all, biotech will also become ubiquitous. A good example of the flexible and adaptable nature of biotech is the STOP (SHERLOCK Testing in One Pot) COVID-19 test developed by Feng Zhang, which only requires that the pot be kept at 140 degrees Fahrenheit. According to Zhang, the test can be adapted to the flu, HIV, and other viruses. Such tests will be available in people’s homes in the not-so-distant future.
Throughout the text, Isaacson speaks of biotech and tech geniuses like Doudna and Steve Jobs in the same breath, establishing a continuum between the two segments. Both revolutions involve a code; however, gene editing holds the thrilling and scandalous promise of editing human DNA. Forget coding microchips, coding the DNA of offspring may be possible in the near future. Because of the biotech takeover, and the ethical questions around genetic editing, Isaacson suggests everyone should learn more about the technology. When people are better informed about the gene-editing process, they will be equipped to form an informed view about its ramifications. Besides, ignoring gene editing is futile, as iconoclasts are already performing CRISPR edits in their garages, as in the case of biohacker Josiah Zayner, who developed a homegrown vaccine for COVID-19 and injected himself with it. The text suggests people like Zayner are important in their own way; the COVID-19 crisis has shown that getting more citizens involved in science is always a good thing. Biohackers like Zayner can be enlisted to crowdsource viral codes or perform contact tracing in case of a pandemic.
Finally, pandemics like COVID-19 are not one-off events. Globalization and growing disruptions of the biosphere mean waves of the next big virus are not far off. The biotech revolution can help people prepare for future pandemics. For instance, a technology like CRISPR, which is essentially an adaptation of bacteria’s antiviral mechanism, targets viruses rather than the immune system. This is a great thing, since treatments that target the immune system can sometimes backfire. Being ready with a virus-killing therapy ensures better prospects for combatting the next global health crisis. Imagine if everyone could detect and kill a new virus before it snowballed into a pandemic. That is biotech’s biggest promise in contemporary times.
By Walter Isaacson
Feminist Reads
View Collection
Health & Medicine
View Collection
Inspiring Biographies
View Collection
New York Times Best Sellers
View Collection
Science & Nature
View Collection
SuperSummary New Releases
View Collection
SuperSummary Staff Picks
View Collection
Teams & Gangs
View Collection
Women's Studies
View Collection